BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1723099)

  • 1. The effect of dihydropyridine calcium channel agents on 5-HT metabolism in the CNS of the rat.
    Colado MI; Alfaro MJ; López F; Del Val V; Martín MI
    J Pharm Pharmacol; 1991 Sep; 43(9):662-4. PubMed ID: 1723099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of glycine responses by dihydropyridines and verapamil in rat spinal neurons.
    Chesnoy-Marchais D; Cathala L
    Eur J Neurosci; 2001 Jun; 13(12):2195-204. PubMed ID: 11454022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of [3H]serotonin release by dihydropyridines in spinal cord synaptosomes.
    Gandhi VC; Jones DJ
    Eur J Pharmacol; 1990 Oct; 187(2):271-80. PubMed ID: 1703081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of strychnine on the regulation of voltage-dependent calcium channels by dihydropyridines in brain and heart.
    O'Neill SK; Bolger GT
    Pharmacol Biochem Behav; 1990 Apr; 35(4):833-40. PubMed ID: 1693213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturation of rat cerebellar Purkinje cells reveals an atypical Ca2+ channel current that is inhibited by omega-agatoxin IVA and the dihydropyridine (-)-(S)-Bay K8644.
    Tringham EW; Payne CE; Dupere JR; Usowicz MM
    J Physiol; 2007 Feb; 578(Pt 3):693-714. PubMed ID: 17124267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MPC-1304, another type of dihydropyridine, possessing highly potent vasodilating action.
    Miyoshi K; Kanda A; Miyake H; Ichihara K; Kamei H; Nagasaka M
    Eur J Pharmacol; 1993 Jul; 238(2-3):139-48. PubMed ID: 7691619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Bay K 8644 on the synthesis and metabolism of dopamine and 5-hydroxytryptamine in various brain areas of the rat.
    Colado MI; Ormazabal MJ; Alfaro MJ; Martin MI
    J Pharm Pharmacol; 1993 Mar; 45(3):220-2. PubMed ID: 7683338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant properties of calcium channel blockers in mice: N-methyl-D-,L-aspartate- and Bay K 8644-induced convulsions are potently blocked by the dihydropyridines.
    Palmer GC; Stagnitto ML; Ray RK; Knowles MA; Harvey R; Garske GE
    Epilepsia; 1993; 34(2):372-80. PubMed ID: 7681002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of dihydropyridine calcium channel modulators on pentylenetetrazole convulsions.
    O'Neill SK; Bolger GT
    Brain Res Bull; 1990 Jul; 25(1):211-4. PubMed ID: 1698518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages.
    Szabó C; Thiemermann C; Vane JR
    Biochem Biophys Res Commun; 1993 Oct; 196(2):825-30. PubMed ID: 7694580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of neurotransmitter metabolism by dihydropyridine calcium channel ligands in mouse brain.
    Bolger GT; Lesieur P; Basile AS; Skolnick P
    Brain Res; 1988 Jan; 438(1-2):101-7. PubMed ID: 2449929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
    Zahradníková A; Minarovic I; Zahradník I
    J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant profile of the dihydropyridine calcium channel antagonists, nitrendipine and nimodipine.
    Dolin SJ; Hunter AB; Halsey MJ; Little HJ
    Eur J Pharmacol; 1988 Jul; 152(1-2):19-27. PubMed ID: 2463174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of different types of voltage-sensitive calcium channels in the presynaptic regulation of noradrenaline release in rat brain cortex and hippocampus.
    Sabrià J; Pastor C; Clos MV; Garcia A; Badia A
    J Neurochem; 1995 Jun; 64(6):2567-71. PubMed ID: 7539054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel activation: a different type of drug action.
    Freedman SB; Miller RJ
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5580-3. PubMed ID: 6206501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yawning induced by apomorphine, physostigmine or pilocarpine is potentiated by dihydropyridine calcium channel blockers.
    Bourson A; Moser PC
    Psychopharmacology (Berl); 1990; 100(2):168-72. PubMed ID: 1689500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dihydropyridine Ca2+ channel blockers on the discriminative stimulus and the motor impairing effects of (+/-)-Bay K 8644.
    Cohen C; Perrault G; Sanger DJ
    Eur J Pharmacol; 1997 Oct; 336(2-3):113-21. PubMed ID: 9384222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium depolarization elevates cytosolic free calcium concentration in rat anterior pituitary cells through 1,4-dihydropyridine-sensitive, omega-conotoxin-insensitive calcium channels.
    Meier K; Knepel W; Schöfl C
    Endocrinology; 1988 Jun; 122(6):2764-70. PubMed ID: 2453348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydropyridine calcium agonist and antagonist effects on aldosterone secretion.
    Kojima K; Kojima I; Rasmussen H
    Am J Physiol; 1984 Nov; 247(5 Pt 1):E645-50. PubMed ID: 6208793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.